CCMI
CRL icon

Creative Capital Management Investments’s Charles River Laboratories CRL Stock Holding History

Creative Capital Management Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.95K Buy
+13
New +$2.31K ﹤0.01% 636

Other funds holding CRL

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return

Creative Capital Management Investments's CRL Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Charles River Laboratories (CRL) in Q2 2026: 13 shares worth $2.95K. The stake represents ﹤0.01% of the portfolio and ranks #636 among its holdings.

105 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Creative Capital Management Investments held 13 shares of Charles River Laboratories worth $2.95K as of Q2 2026.
  • Charles River Laboratories was a new Creative Capital Management Investments position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #636 holding.
  • 105 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.